Depo-SubQ Provera
- Product NDC
- 0009-4709
- 11-digit product format
- 000094709
- Labeler code
- 0009
- Product ID
- 0009-4709_641b0fea-8376-4405-aea2-ac972c4a65eb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- medroxyprogesterone acetate
- Dosage form
- INJECTION, SUSPENSION
- Route
- SUBCUTANEOUS
- Labeler
- Pharmacia & Upjohn Company LLC
- Application
- NDA021583
- Marketing category
- NDA
- Marketing start
- 2005-05-02
- Substance
- MEDROXYPROGESTERONE ACETATE
- Active strength
- 104 mg/.65mL
- Pharmacologic classes
- Progesterone Congeners [CS], Progestin [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Depo-SubQ Provera
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| MEDROXYPROGESTERONE ACETATE | 104 mg/.65mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | C2QI4IOI2G |
| Rxcui | 1000156, 1000158 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0009-4709-13 | Depo-SubQ Provera | 0.65 mL in 1 SYRINGE | INJECTION, SUSPENSION | 0.65 | | 21 |
| 0009-4709-13 | Depo-SubQ Provera | 1 in 1 CARTON | INJECTION, SUSPENSION | 1 | | 21 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| MEDROXYPROGESTERONE ACETATE | ACTIVE INGREDIENT | C2QI4IOI2G | DEPO-SUBQ PROVERA (MEDROXYPROGESTERONE ACETATE) INJECTION, SUSPENSION [PHARMACIA AND UPJOHN COMPANY] | 11 | |
| MEDROXYPROGESTERONE | ACTIVE MOIETY | HSU1C9YRES | DEPO-SUBQ PROVERA (MEDROXYPROGESTERONE ACETATE) INJECTION, SUSPENSION [PHARMACIA AND UPJOHN COMPANY] | 11 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | DEPO-SUBQ PROVERA (MEDROXYPROGESTERONE ACETATE) INJECTION, SUSPENSION [PHARMACIA AND UPJOHN COMPANY] | 11 | |
| METHIONINE | INACTIVE INGREDIENT | AE28F7PNPL | DEPO-SUBQ PROVERA (MEDROXYPROGESTERONE ACETATE) INJECTION, SUSPENSION [PHARMACIA AND UPJOHN COMPANY] | 11 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | DEPO-SUBQ PROVERA (MEDROXYPROGESTERONE ACETATE) INJECTION, SUSPENSION [PHARMACIA AND UPJOHN COMPANY] | 11 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | DEPO-SUBQ PROVERA (MEDROXYPROGESTERONE ACETATE) INJECTION, SUSPENSION [PHARMACIA AND UPJOHN COMPANY] | 11 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | DEPO-SUBQ PROVERA (MEDROXYPROGESTERONE ACETATE) INJECTION, SUSPENSION [PHARMACIA AND UPJOHN COMPANY] | 11 | |
| POVIDONES | INACTIVE INGREDIENT | FZ989GH94E | DEPO-SUBQ PROVERA (MEDROXYPROGESTERONE ACETATE) INJECTION, SUSPENSION [PHARMACIA AND UPJOHN COMPANY] | 11 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | DEPO-SUBQ PROVERA (MEDROXYPROGESTERONE ACETATE) INJECTION, SUSPENSION [PHARMACIA AND UPJOHN COMPANY] | 11 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | DEPO-SUBQ PROVERA (MEDROXYPROGESTERONE ACETATE) INJECTION, SUSPENSION [PHARMACIA AND UPJOHN COMPANY] | 11 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | DEPO-SUBQ PROVERA (MEDROXYPROGESTERONE ACETATE) INJECTION, SUSPENSION [PHARMACIA AND UPJOHN COMPANY] | 11 | |
| SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | 22ADO53M6F | DEPO-SUBQ PROVERA (MEDROXYPROGESTERONE ACETATE) INJECTION, SUSPENSION [PHARMACIA AND UPJOHN COMPANY] | 11 | |
| SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | INACTIVE INGREDIENT | KH7I04HPUU | DEPO-SUBQ PROVERA (MEDROXYPROGESTERONE ACETATE) INJECTION, SUSPENSION [PHARMACIA AND UPJOHN COMPANY] | 11 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | DEPO-SUBQ PROVERA (MEDROXYPROGESTERONE ACETATE) INJECTION, SUSPENSION [PHARMACIA AND UPJOHN COMPANY] | 11 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0009-4709 | DEPO-SUBQ PROVERA (MEDROXYPROGESTERONE ACETATE) INJECTION, SUSPENSION [PHARMACIA & UPJOHN COMPANY LLC] | 19 | Current NDC, Legacy NDC, 2 package rows | 20241228_390087a6-f3c3-4f0b-a930-79acf412f153.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0009-4709-13 | 00009470913 | 1 SYRINGE in 1 CARTON (0009-4709-13) / .65 mL in 1 SYRINGE | 1 syringe | 2005-05-02 | 0000-00-00 | No | No | Current |